VRDN Historical PE Ratio image   This VRDN PE ratio history page last updated 3/13/2024
VRDN PE History Chart
PeriodPriceGAAPTTMPE
Q4 2023
2/27/2024
19.61-1.35-5.32NA
Q3 2023
11/13/2023
13.99-1.09-5.10NA
Q2 2023
8/8/2023
18.75-1.27-4.87NA
Q1 2023
5/9/2023
25.68-1.61-4.66NA
Q4 2022
3/8/2023
29.47-1.13-4.03NA
Q3 2022
11/14/2022
20.32-0.86-4.22NA
Q2 2022
8/15/2022
22.00-1.06-4.61NA
Q1 2022
5/12/2022
10.56-0.98-5.76NA
Q4 2021
3/10/2022
19.04-1.32-7.69NA
Q3 2021
11/4/2021
18.09-1.25-11.68NA
Q2 2021
8/11/2021
12.05-2.21-10.53NA
Q1 2021
5/6/2021
17.36-2.91-8.44NA
Q4 2020
3/25/2021
17.27-5.31-5.71NA
Q3 2020
11/10/2020
1.08-0.10-0.71NA
Q2 2020
8/5/2020
1.17-0.12-0.97NA
Q1 2020
5/7/2020
0.55-0.18-1.14NA
Q4 2019
3/11/2020
0.61-0.31-1.34NA
Q3 2019
11/7/2019
0.71-0.36-1.36NA
Q2 2019
8/7/2019
1.57-0.29-1.29NA
Q1 2019
5/8/2019
2.81-0.38-1.29NA
Q4 2018
3/13/2019
2.65-0.33-1.09NA
Q3 2018
11/7/2018
4.37-0.29-1.05NA
Q2 2018
8/7/2018
6.29-0.29NANA
Q1 2018
5/9/2018
7.56-0.18NANA
Q4 2017
3/14/2018
7.05-0.29NANA
VRDN Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q4 2023
2/27/2024
19.61-1.35-5.40NA
Q3 2023
11/13/2023
13.99-1.09-4.36NA
Q2 2023
8/8/2023
18.75-1.27-5.08NA
Q1 2023
5/9/2023
25.68-1.61-6.44NA
Q4 2022
3/8/2023
29.47-1.13-4.52NA
Q3 2022
11/14/2022
20.32-0.86-3.44NA
Q2 2022
8/15/2022
22.00-1.06-4.24NA
Q1 2022
5/12/2022
10.56-0.98-3.92NA
Q4 2021
3/10/2022
19.04-1.32-5.28NA
Q3 2021
11/4/2021
18.09-1.25-5.00NA
Q2 2021
8/11/2021
12.05-2.21-8.84NA
Q1 2021
5/6/2021
17.36-2.91-11.64NA
Q4 2020
3/25/2021
17.27-5.31-21.24NA
Q3 2020
11/10/2020
1.08-0.10-0.40NA
Q2 2020
8/5/2020
1.17-0.12-0.48NA
Q1 2020
5/7/2020
0.55-0.18-0.72NA
Q4 2019
3/11/2020
0.61-0.31-1.24NA
Q3 2019
11/7/2019
0.71-0.36-1.44NA
Q2 2019
8/7/2019
1.57-0.29-1.16NA
Q1 2019
5/8/2019
2.81-0.38-1.52NA
Q4 2018
3/13/2019
2.65-0.33-1.32NA
Q3 2018
11/7/2018
4.37-0.29-1.16NA
Q2 2018
8/7/2018
6.29-0.29-1.16NA
Q1 2018
5/9/2018
7.56-0.18-0.72NA
Q4 2017
3/14/2018
7.05-0.29-1.16NA
Quotes delayed 20 minutes

Email EnvelopeFree VRDN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Viridian Therapeutics (VRDN) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

VREX PE Ratio History
VRPX PE Ratio History
VRTX PE Ratio History
VSTM PE Ratio History
VTGN PE Ratio History
VTRS PE Ratio History
VTVT PE Ratio History
VTYX PE Ratio History
VVOS PE Ratio History
VXRT PE Ratio History
On this page we presented the VRDN PE Ratio History information for Viridian Therapeutics' stock. The average VRDN PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average VRDN PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this VRDN PE ratio history result, against the recent PE: when this page was posted on 3/12/2024, the most recent closing price for VRDN had been 17.60, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on VRDN or any other given stock, valuation analysis for VRDN can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Viridian Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for VRDN. Thanks for visiting, and the next time you need to research VRDN PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: Institutional Holders of IBDK, FXI YTD Return, Top Ten Hedge Funds Holding RLTY.

 

VRDN PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.